| Literature DB >> 32731471 |
Maodong Zhang1, Yanyun Huang1,2, Dale L Godson2,3, Champika Fernando3, Trevor W Alexander4, Janet E Hill3.
Abstract
High throughput sequencing is currently revolutionizing the genomics field and providing new approaches to the detection and characterization of microorganisms. The objective of this study was to assess the detection of influenza D virus (IDV) in bovine respiratory tract samples using two sequencing platforms (MiSeq and Nanopore (GridION)), and species-specific qPCR. An IDV-specific qPCR was performed on 232 samples (116 nasal swabs and 116 tracheal washes) that had been previously subject to virome sequencing using MiSeq. Nanopore sequencing was performed on 19 samples positive for IDV by either MiSeq or qPCR. Nanopore sequence data was analyzed by two bioinformatics methods: What's In My Pot (WIMP, on the EPI2ME platform), and an in-house developed analysis pipeline. The agreement of IDV detection between qPCR and MiSeq was 82.3%, between qPCR and Nanopore was 57.9% (in-house) and 84.2% (WIMP), and between MiSeq and Nanopore was 89.5% (in-house) and 73.7% (WIMP). IDV was detected by MiSeq in 14 of 17 IDV qPCR-positive samples with Cq (cycle quantification) values below 31, despite multiplexing 50 samples for sequencing. When qPCR was regarded as the gold standard, the sensitivity and specificity of MiSeq sequence detection were 28.3% and 98.9%, respectively. We conclude that both MiSeq and Nanopore sequencing are capable of detecting IDV in clinical specimens with a range of Cq values. Sensitivity may be further improved by optimizing sequence data analysis, improving virus enrichment, or reducing the degree of multiplexing.Entities:
Keywords: Illumina MiSeq sequencing; bovine respiratory disease; diagnostics; influenza D virus; nanopore GridION sequencing; qPCR
Year: 2020 PMID: 32731471 PMCID: PMC7472010 DOI: 10.3390/v12080814
Source DB: PubMed Journal: Viruses ISSN: 1999-4915 Impact factor: 5.048
Figure 1Workflow for GridION Nanopore sequencing, MiSeq sequencing, and qPCR of bovine respiratory tract samples (BRD). (a) The workflow illustrates both the sample and library preparation. Extracted RNA was used directly for qPCR, while DNA randomly amplified from the same extracts was used for MiSeq sequencing and GridION Nanopore sequencing; (b) Bioinformatic workflow to identify viruses in BRD samples. WIMP (What’s In My Pot) analysis was used only for Nanopore data. The remaining analysis was the same for data from both MiSeq and GridION Nanopore sequencing except Minimap2 was used instead of Bowtie2 for host sequence subtraction.
Figure 2Cq values and MiSeq detection results for 53 samples positive by IDV qPCR. Samples positive for both qPCR and MiSeq are indicated by red dots. Most concurrent detection by MiSeq and qPCR occurred in samples with Cq values <31 (dotted line). Samples selected for Nanopore sequencing are indicated with their respective sample identification number.
Figure 3Proportions of reads corresponding to host, viruses or other taxa (bacteria, fungi, unclassified) from 19 IDV-positive samples sequenced using Nanopore sequencing (WIMP) (left bar in each pair) and MiSeq sequencing (right bar). Labels on the x-axis indicate individual specimens; tracheal samples are denoted by “T” before animal number.
Summary of data from Nanopore, MiSeq and qPCR on detection of influenza D virus (IDV) for each individual sample.
| Sample * | Cq Value | Copy Number | Number (%) of IDV Reads | Largest IDV Contig (bp) | Total Input Reads | ||||
|---|---|---|---|---|---|---|---|---|---|
| Nanopore (WIMP) | Nanopore | MiSeq | Nanopore | MiSeq | Nanopore | MiSeq | |||
| 129 | 16.99 | 6.25 × 107 | 321,638 (14.69) | 606,932 (27.72) | 2182 (1.48) | 2030 | 951 | 2,188,805 | 147,341 |
| 114 | 17.53 | 1.31 × 107 | 8 (<0.01) | ND | ND | N/A | N/A | 335,559 | 136,961 |
| 50 | 20.71 | 1.25 × 106 | 1088 (5.74) | 1625 (8.57) | 162 (1.1) | 1161 | 498 | 18,966 | 14,719 |
| 69 | 21.69 | 4.48 × 105 | 944 (7.83) | 2287 (18.97) | 1812 (0.69) | 980 | 842 | 12,053 | 263,262 |
| 42 | 22.04 | 2.86 × 105 | 608 (0.34) | 584 (0.33) | 26 (0.07) | 986 | 499 | 179,559 | 37,560 |
| 6 | 23.33 | 2.16 × 105 | 281 (1.44) | 350 (1.8) | 183 (0.08) | 1034 | 522 | 19,512 | 228,875 |
| 10 | 24.09 | 1.31 × 105 | 1656 (1.17) | 1650 (1.11) | 87 (0.2) | 1359 | 485 | 148,381 | 44,433 |
| 199 | 26.01 | 4.64 × 104 | 4211 (10.99) | 10861 (28.34) | 3250 (1.49) | 2308 | 552 | 38,329 | 218,800 |
| T50 | 26.76 | 2.93 × 104 | 3 (<0.01) | ND | ND | N/A | N/A | 43,193 | 1,256,918 |
| T129 | 28.20 | 8.00 × 103 | 403 (0.23) | 502 (0.28) | 34 (<0.01) | 843 | 327 | 177,706 | 444,979 |
| 70 | 28.71 | 5.70 × 103 | 2 (0.02) | ND | ND | N/A | N/A | 12,211 | 160,704 |
| T10 | 29.15 | 5.50 × 103 | 29 (0.54) | ND | 455 (0.03) | N/A | 913 | 5,413 | 1,415,256 |
| 13 | 29.22 | 4.15 × 103 | 116 (0.10) | 152 (0.13) | 48 (0.04) | 626 | 470 | 119,073 | 132,847 |
| 32 | 33.60 | 2.18 × 102 | ND | ND | ND | N/A | N/A | 275,387 | 32,312 |
| 170 | 35.62 | 8.25 × 101 | 1080 (2.03) | 1991 (3.75) | 8167 (0.74) | 903 | 1,584 | 53,131 | 1,100,167 |
| 135 | 36.51 | 4.88 × 101 | 10 (<0.01) | ND | ND | N/A | N/A | 142,737 | 154,220 |
| 260 | 39.46 | 6.88 | 9 (<0.01) | ND | ND | N/A | N/A | 164,607 | 959,935 |
| T30 | ND | - | 3 (<0.01) | ND | 2 (<0.01) | N/A | 249 | 139,037 | 1,156,213 |
| T52 | ND | - | 51 (0.1) | 52 (0.1) | 497 (0.05) | 1616 | 1,341 | 51,180 | 930,628 |
Cq = quantification cycle; ND = not detected; WIMP = What’s In My Pot; bp = basepair; * Samples beginning with T are tracheal, all others are nasal swabs.